Emicizumab
Emicizumab is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab can be used for hemophilia A research[1].
Product Specifications
CAS Number
[1610943-06-0]
Product Name Alternative
ACE-910; RG6013
UNSPSC
12352203
Target
Factor VIII
Type
Inhibitory Antibodies
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/emicizumab.html
Purity
95.00
Solubility
H2O
Smiles
[Emicizumab]
Molecular Weight
(145.5 kDa)
References & Citations
[1]Ferrière S, et al. A hemophilia A mouse model for the in vivo assessment of emicizumab function. Blood. 2020 Aug 6;136 (6) :740-748.
Shipping Conditions
Blue Ice
Storage Conditions
Store at 4°C for 2 years, do not freeze
Badge
Hot
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
PO55063M2 100 µg
Influenza A H7N9 (A/Anhui/1/2013) Hemagglutinin Protein (HA1 Subunit) (His Tag)
Ask
View Details